GATA4 sequence variants in patients with congenital heart disease

A. Tomita-Mitchell, Cheryl Maslen, Cynthia Morris, V. Garg, E. Goldmuntz

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Background: Recent reports have identified mutations in the transcription factor GATA4 in familial cases of cardiac septal defects. The prevalence of GATA4 mutations in the population of patients with septal defects is unknown. Given that patients with septal and conotruncal defect can share a common genetic basis, it is unclear whether patients with additional types of CHD might also have GATA4 mutations. Aims: To explore these questions by investigating a large population of 628 patients with either septal or conotruncal defects for GATA4 sequence variants. Methods: The GATA4 coding region and exon-intron boundaries were investigated for sequence variants using denaturing high-performance liquid chromatography or conformation-sensitive gel electrophoresis. Samples showing peak or band shifts were reamplified from genomic DNA and sequenced. Results: Four missense sequence variants (Gly93Ala, Gln316Glu, Ala411Val, Asp425Asn) were identified in five patients (two with atrial septal defect, two with ventricular septal defect and one with tetralogy of Fallot), which were not seen in a control population. All four affected amino acid residues are conserved across species, and two of the sequence variants lead to changes in polarity. Ten synonymous sequence variants were also identified in 18 patients, which were not seen in the control population. Conclusions: These data suggest that non-synonymous GATA4 sequence variants are found in a small percentage of patients with septal defects and are very uncommonly found in patients with conotruncal defects.

Original languageEnglish (US)
Pages (from-to)779-783
Number of pages5
JournalJournal of Medical Genetics
Volume44
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Heart Diseases
Mutation
Population
Heart Septal Defects
GATA4 Transcription Factor
Tetralogy of Fallot
Atrial Heart Septal Defects
Ventricular Heart Septal Defects
Introns
Electrophoresis
Exons
Gels
High Pressure Liquid Chromatography
Amino Acids
DNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

GATA4 sequence variants in patients with congenital heart disease. / Tomita-Mitchell, A.; Maslen, Cheryl; Morris, Cynthia; Garg, V.; Goldmuntz, E.

In: Journal of Medical Genetics, Vol. 44, No. 12, 12.2007, p. 779-783.

Research output: Contribution to journalArticle

Tomita-Mitchell, A. ; Maslen, Cheryl ; Morris, Cynthia ; Garg, V. ; Goldmuntz, E. / GATA4 sequence variants in patients with congenital heart disease. In: Journal of Medical Genetics. 2007 ; Vol. 44, No. 12. pp. 779-783.
@article{4f4e6ea466534095a01e62bef5384a8b,
title = "GATA4 sequence variants in patients with congenital heart disease",
abstract = "Background: Recent reports have identified mutations in the transcription factor GATA4 in familial cases of cardiac septal defects. The prevalence of GATA4 mutations in the population of patients with septal defects is unknown. Given that patients with septal and conotruncal defect can share a common genetic basis, it is unclear whether patients with additional types of CHD might also have GATA4 mutations. Aims: To explore these questions by investigating a large population of 628 patients with either septal or conotruncal defects for GATA4 sequence variants. Methods: The GATA4 coding region and exon-intron boundaries were investigated for sequence variants using denaturing high-performance liquid chromatography or conformation-sensitive gel electrophoresis. Samples showing peak or band shifts were reamplified from genomic DNA and sequenced. Results: Four missense sequence variants (Gly93Ala, Gln316Glu, Ala411Val, Asp425Asn) were identified in five patients (two with atrial septal defect, two with ventricular septal defect and one with tetralogy of Fallot), which were not seen in a control population. All four affected amino acid residues are conserved across species, and two of the sequence variants lead to changes in polarity. Ten synonymous sequence variants were also identified in 18 patients, which were not seen in the control population. Conclusions: These data suggest that non-synonymous GATA4 sequence variants are found in a small percentage of patients with septal defects and are very uncommonly found in patients with conotruncal defects.",
author = "A. Tomita-Mitchell and Cheryl Maslen and Cynthia Morris and V. Garg and E. Goldmuntz",
year = "2007",
month = "12",
doi = "10.1136/jmg.2007.052183",
language = "English (US)",
volume = "44",
pages = "779--783",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - GATA4 sequence variants in patients with congenital heart disease

AU - Tomita-Mitchell, A.

AU - Maslen, Cheryl

AU - Morris, Cynthia

AU - Garg, V.

AU - Goldmuntz, E.

PY - 2007/12

Y1 - 2007/12

N2 - Background: Recent reports have identified mutations in the transcription factor GATA4 in familial cases of cardiac septal defects. The prevalence of GATA4 mutations in the population of patients with septal defects is unknown. Given that patients with septal and conotruncal defect can share a common genetic basis, it is unclear whether patients with additional types of CHD might also have GATA4 mutations. Aims: To explore these questions by investigating a large population of 628 patients with either septal or conotruncal defects for GATA4 sequence variants. Methods: The GATA4 coding region and exon-intron boundaries were investigated for sequence variants using denaturing high-performance liquid chromatography or conformation-sensitive gel electrophoresis. Samples showing peak or band shifts were reamplified from genomic DNA and sequenced. Results: Four missense sequence variants (Gly93Ala, Gln316Glu, Ala411Val, Asp425Asn) were identified in five patients (two with atrial septal defect, two with ventricular septal defect and one with tetralogy of Fallot), which were not seen in a control population. All four affected amino acid residues are conserved across species, and two of the sequence variants lead to changes in polarity. Ten synonymous sequence variants were also identified in 18 patients, which were not seen in the control population. Conclusions: These data suggest that non-synonymous GATA4 sequence variants are found in a small percentage of patients with septal defects and are very uncommonly found in patients with conotruncal defects.

AB - Background: Recent reports have identified mutations in the transcription factor GATA4 in familial cases of cardiac septal defects. The prevalence of GATA4 mutations in the population of patients with septal defects is unknown. Given that patients with septal and conotruncal defect can share a common genetic basis, it is unclear whether patients with additional types of CHD might also have GATA4 mutations. Aims: To explore these questions by investigating a large population of 628 patients with either septal or conotruncal defects for GATA4 sequence variants. Methods: The GATA4 coding region and exon-intron boundaries were investigated for sequence variants using denaturing high-performance liquid chromatography or conformation-sensitive gel electrophoresis. Samples showing peak or band shifts were reamplified from genomic DNA and sequenced. Results: Four missense sequence variants (Gly93Ala, Gln316Glu, Ala411Val, Asp425Asn) were identified in five patients (two with atrial septal defect, two with ventricular septal defect and one with tetralogy of Fallot), which were not seen in a control population. All four affected amino acid residues are conserved across species, and two of the sequence variants lead to changes in polarity. Ten synonymous sequence variants were also identified in 18 patients, which were not seen in the control population. Conclusions: These data suggest that non-synonymous GATA4 sequence variants are found in a small percentage of patients with septal defects and are very uncommonly found in patients with conotruncal defects.

UR - http://www.scopus.com/inward/record.url?scp=37249090635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249090635&partnerID=8YFLogxK

U2 - 10.1136/jmg.2007.052183

DO - 10.1136/jmg.2007.052183

M3 - Article

C2 - 18055909

AN - SCOPUS:37249090635

VL - 44

SP - 779

EP - 783

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 12

ER -